Literature DB >> 1683673

Antimicrobial therapy for otitis media with effusion ('secretory' otitis media).

E I Cantekin1, T W McGuire, T L Griffith.   

Abstract

OBJECTIVE: To determine the effectiveness of antimicrobial treatment for otitis media with effusion ("secretory" otitis media) in children. DATA SOURCE: We report the reexamination of a previously published study by Mandel et al that evaluated the efficacy of a 2-week course of antimicrobials (amoxicillin trihydrate) with and without a 4-week course of an oral decongestant-antihistamine combination in a double-blind, placebo-controlled, randomized trial involving 518 infants and children with otitis media with effusion. DATA SYNTHESIS: At 4 weeks, amoxicillin efficacy as determined by a tympanometric criterion (P = .121) or by a measure of improvement in hearing (P = .311) was insignificant. Only by otoscopic judgment, which is shown to contain a systematic bias as used in this clinical trial, could an argument be made for a marginal efficacy of amoxicillin at the 4-week end point. Logistic regression analyses of the combined effects of treatment and prognostic factors showed no significant differences between placebo- and antibiotic-treated groups for unilateral effusions and for bilateral effusions. When subjects with unilateral and bilateral effusions were combined, the estimated efficacy of antibiotic treatment was 12.3% by otoscopy (P = .014) and 4.8% by tympanometry (P = .171). We also demonstrate the sensitivity of outcome to diagnostic measures used and provide statistical evidence questioning the validity of otoscopic observations in this study. Six weeks after the termination of amoxicillin therapy, the recurrence of effusion was two to six times higher in the amoxicillin-treated children than in those treated with placebo (P = .001), and resolution of effusion was not significantly different among antibiotic and placebo groups (13.6% and 11.3%, respectively; P = .477).
CONCLUSIONS: Amoxicillin with and without decongestant-antihistamine combination is not effective for the treatment of persistent asymptomatic middle-ear effusions in infants and children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683673

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  alpha Streptococci and recurrences of otitis media. Right choice of antibiotic can decrease risk of recurrence.

Authors:  V P Joki-Erkkilä; J Pukander
Journal:  BMJ       Date:  2001-06-23

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

Review 3.  Postmarketing surveillance of quinolones, 1990 to 1992.

Authors:  P Davey; T McDonald
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Increasing the accessibility of data.

Authors:  G D Smith
Journal:  BMJ       Date:  1994-06-11

Review 5.  Antihistamines and/or decongestants for otitis media with effusion (OME) in children.

Authors:  Glenn Griffin; Cheryl A Flynn
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

6.  Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion.

Authors:  A Pitkäranta; J Jero; E Arruda; A Virolainen; F G Hayden
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

Review 7.  Antibiotics for otitis media with effusion in children.

Authors:  Roderick P Venekamp; Martin J Burton; Thijs M A van Dongen; Geert J van der Heijden; Alice van Zon; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.